Detalhe da pesquisa
1.
Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome.
Pharm Stat
; 13(2): 145-52, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24523155
2.
DNA alteration-based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high-risk group.
Cancer Med
; 8(6): 3036-3046, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025552